Ninmy Mathews
FDA investigator
Appears on 1 document from 2017, mostly at sites in Arkansas. Most often cites design and construction features (21 CFR 211.42(c)(10)(iv)).
- 1
- Documents on file
- 6.0
- Observations per 483
- 2017
- First seen
- 2017
- Most recent
What they cite most
From 6 observations- 21 CFR 211.42(c)(10)(iv)Design and construction features2
- 21 CFR 211.113(b)Control of microbiological contamination1
- 21 CFR 211.192Production record review1
- 21 CFR 211.28(a)Personnel responsibilities1
- FDCA 503B(a)(10)1
Activity by year
2017: 1
Where
Arkansas 1
Often inspects with
Is Ninmy Mathews coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2017-09-29 | 483 SCA Pharmaceuticals, LLCSep 29, 2017 · Little Rock, Arkansas | Little Rock, Arkansas | 6 |
About this profile
What does Ninmy Mathews inspect?
Ninmy Mathews appears on 1 document on file covering 1 site, mostly in Arkansas.
What do they cite most often?
21 CFR 211.42(c)(10)(iv) (design and construction features), followed by 21 CFR 211.113(b) and 21 CFR 211.192.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Ninmy Mathews is dated Sep 29, 2017.